NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. (AURX) Stock Price, Quote, News & History

Key Statistics

Open

$1.25

$1.30

Volume / Avg.

2.10K / 4.98K

Day Range

$1.25 - $1.30

52 Wk Range

0.77 - 3.23

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Nuo Therapeutics Inc News

Container Store Group And 2 Other Penny Stocks Insiders Are Buying

The Dow Jones closed lower by around 150 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

4 Stocks Under $3 Insiders Are Aggressively Buying

Gold futures traded slightly higher on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

PRO
Roth Capital Initiates Coverage On Nuo Therapeutics with Buy Rating, Announces Price Target of $3

Roth Capital analyst Kyle Bauser initiates coverage on Nuo Therapeutics (OTC:AURX) with a Buy rating and announces Price Target of $3.

Benzinga Newsdesk

PRO
Nuo Therapeutics Enters Into Exclusive Private Label Distribution Agreement With Global Medical Technology Company For The CENTRIO Platelet-Rich Plasma System

Nuo Therapeutics, Inc. (OTCQB:AURX) ("Nuo"), a commercial stage medical device company pioneering leading-edge biodynamic therapies by focusing on emerging opportunities in the evolving healthcare landscape, announced it

Benzinga Newsdesk

Audeo Oncology Files to Withdraw S-1 for IPO

Benzinga

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-2.15M

Investing Cash Flow (TTM)

-297.08K

Financing Cash Flow (TTM)

2.58M

Free Cash Flow (TTM)

-2.45M

Capital Expenditure (TTM)

-297.08K

Net Change in Cash (TTM)

132.97K

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$61.42M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

11.46

PB Ratio (TTM)

Earnings Yield % (TTM)

-3.23%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$0.03

Company Debt

Total Debt

$1.75M

LT Debt

$1.75M

LT Debt Issuance (TTM)

$1.68M

LT Debt Repayment (TTM)

Total Cash

$449.33K

Debt to Equity

Issuance of Debt (TTM)

$1.68M

Repayment of Debt (TTM)

Key Statistics

Open

$1.25

$1.30

Volume / Avg.

2.10K / 4.98K

Day Range

$1.25 - $1.30

52 Wk Range

0.77 - 3.23

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

N/A

Industry

N/A

Nuo Therapeutics Inc is a commercial-stage medical device company engaged in developing and marketing products for chronic wound care. The company operates as a single segment focused on regenerative therapies that utilize autologous (patient-derived...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

AURX

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

AURX

FAQ

How do I buy NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. (AURX) stock?

You can purchase shares of NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. (OTCQB:AURX) through any online brokerage.

View our list of the best stock brokerages

Who are NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. (AURX) competitors?

There are no as such competitors for NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc..

What is the forecast, or price target, for NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. (AURX) stock?

NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. has a consensus price target of $3.00.

What is the current price for NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. (AURX)?

The stock price for NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. (OTCQB: AURX) is $2.55 last updated November 10, 2025 at 4:03 PM EST.

Does NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. (AURX) pay a dividend?

There are no upcoming dividends for NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc..

When is NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. (OTCQB:AURX) reporting earnings?

NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. does not have any upcoming earnings scheduled.

Is NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. (AURX) going to split?

There is no upcoming split for NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc..

What sector and industry does NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. (AURX) operate in?

NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. is in the Healthcare sector and Biotechnology industry. They are listed on the OTCQB.